We could not find any results for:
Make sure your spelling is correct or try broadening your search.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Its targeted patien... ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Its targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune-suppressed for medical reasons. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. Show more
1Q 2024 Total Revenue of $81.9 Million, a 44% Increase Y-o-Y 1Q 2024 GAAP Net Income of $17.8 Million, a $24.6 Million Increase Y-o-Y 1Q 2024 Adjusted EBITDA(1) of $26.4 Million, a 970% Increase...
U.S. index futures are trading lower in pre-market trading on Thursday, halting momentum after the Dow Jones had closed higher for six consecutive sessions, the longest winning streak of 2024 for...
RAMSEY, N.J. and BOCA RATON, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to...
FDA Approval Provides for Room Temperature (25°C) Storage Conditions for up to 4 Weeks at Any Point During the 36-Month Approved Shelf Life Extends the Prior Room Temperature Storage Allowance for...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.1802 | 12.462776405 | 9.4698 | 10.855 | 9.4 | 3514332 | 9.91497725 | CS |
4 | 3.72 | 53.6796536797 | 6.93 | 10.855 | 6.84 | 3675870 | 9.26096342 | CS |
12 | 4.45 | 71.7741935484 | 6.2 | 10.855 | 5.88 | 2790746 | 7.62135954 | CS |
26 | 6.72 | 170.992366412 | 3.93 | 10.855 | 3.6 | 2654395 | 6.34664843 | CS |
52 | 6.61 | 163.613861386 | 4.04 | 10.855 | 3.06 | 2342671 | 5.23230099 | CS |
156 | 8.91 | 512.068965517 | 1.74 | 10.855 | 1.01 | 2568767 | 3.18841945 | CS |
260 | 6.65 | 166.25 | 4 | 10.855 | 1.01 | 2812868 | 2.93275941 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions